WHO Global TB Symposium
-
Room: Auditorium I
Beyond 2015: Ramping Up to End TB
Background
The end of 2015 marks a transition from the Millennium Development Goals (MDGs) to the Sustainable Development Goals (SDGs), including ending the TB epidemic. As envisioned in the WHO End TB Strategy, driving down TB deaths, incidence and eliminating catastrophic costs requires better care and prevention, bolder policies and systems and bigger investments in research and innovation.
2015 has been a year of continued scale-up of key interventions to address all forms of TB, including drug-resistant TB, HIV-associated TB and for all people affected, including men, women and children, persons with co-morbidities and all poor and marginalised groups at special risk. It has also been a year of planning for further acceleration across the three pillars of the End TB Strategy, involving the range of stakeholders, and actions to overcome bottlenecks.
This year’s one-day Global TB Symposium, organised by the World Health Organization, focuses on key stakeholders and their collective actions to revamp and intensify their efforts to meet new End TB targets.
Objectives of the symposium:
- To offer participants an overview of the achievement on the Millennium Development Goal of halting and reversing the TB epidemic, and status on achievement of other 2015 targets.
- To highlight the steps being taken to prepare to implement the End TB Strategy and fundamental links to other Sustainable Development Goals for 2030.
- To discuss the actions being taken by groups of stakeholders, from politicians to global health leaders, TB programme managers, civil society actors and researchers, in pursuing better care and prevention, bolder policies and systems and bigger investments in research and innovation.
- To profile some recent advances in TB research.
Dr Eric Goosby, UN Special Envoy on TB
Dr Philippe Duneton, Deputy Director, UNITAID
Monique Davids, South Africa
Dr Charles Sandy, Ministry of Health, Zimbabwe
Mr Anele Yawa, Treatment Action Campaign
Dr Afranio Kritski, University of Rio de Janeiro; Dr Frank Cobelens, KNCV TB Foundation; Dr Lelisa Fekadu, Ministry of Health, Ethiopia; Dr Gilla Kaplan, Bill & Melinda Gates Foundation
Dr Willem Hanekom, Bill & Melinda Gates Foundation; Dr Madhu Pai, McGill University; Dr Manica Balasegaram, MSF Treatment Access Campaign